Safety and Efficacy Study of Fabulous Stent Graft System for Stanford B Aortic Dissection

Aortic Dissection Type B Clinical Trial

Official title:
Safety and Efficacy Study of Fabulous Stent Graft System for Stanford B Aortic Dissection: A Prospective, Multi-center, Single Arm, Objective Performance Criteria Clinical Trial

Status Completed

Clinical Trial Summary

A prospective, multi-center, objective performance criteria clinical trial to evaluate the safety and efficacy of Fabulous Stent Graft System manufactured by Hangzhou Endonom Medtech Co., Ltd. for Stanford B Aortic Dissection.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04918212
Study type	Interventional
Source	Hangzhou Endonom Medtech Co., Ltd.
Contact
Status	Completed
Phase	N/A
Start date	November 25, 2017
Completion date	October 13, 2020

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05874206` - CRATOS - Evaluation of Cratos™ Branch Stent Graft System in Treatment of Descending Aorta Lesions	N/A
Active, not recruiting	`NCT03033771` - Dragon Study Europe	N/A
Enrolling by invitation	`NCT02726841` - Hybrid Treatment of Type B Aortic Dissection	N/A
Recruiting	`NCT03001739` - Intensive Blood PRessure Control in Patients With Acute Type B AortIc Dissection	Phase 1
Active, not recruiting	`NCT03033043` - Study of the RelayPro Thoracic Stent-Graft in Subjects With an Acute, Complicated Type B Aortic Dissection	N/A